Sign in

CIK 0000906709

  • Non-accelerated filer
  • Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943134940
Phone
+1 415-482-5300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
  1. 4 Open-market sale President & CEO sold 83,333 shares at $75.82 ($6,318,308)
  2. 4 Exercise or conversion Director acquired 33,750 shares (option exercise)
  3. 4 Open-market sale Director sold 30,000 shares at $58.66 ($1,759,800)
  4. 4 Grant or award President & CEO acquired 60,500 shares (grant or award)
  5. 4 Grant or award SVP & Chief Accounting Officer acquired 10,400 shares (grant or award)
  6. 4 Grant or award SVP & Chief Operating Officer acquired 26,000 shares (grant or award)
  7. 4 Grant or award SVP & Chief Financial Officer acquired 26,000 shares (grant or award)
  8. 4 Grant or award SVP Pharma Dev & Mfg Ops acquired 15,000 shares (grant or award)
  9. 4 Grant or award SVP & Chief Scientific Officer acquired 26,000 shares (grant or award)
  10. 4 Open-market sale President & CEO sold 83,333 shares at $55.69 ($4,640,815)
  11. 4 Returned to the company SVP & Chief Accounting Officer returned 5,289 shares (to the company)
  12. 4 Returned to the company President & CEO returned 18,069 shares (to the company)
  13. 4 Returned to the company SVP & Chief Operating Officer returned 6,620 shares (to the company)
  14. 4 Returned to the company SVP & Chief Financial Officer returned 6,698 shares (to the company)
  15. 4 Returned to the company SVP Pharma Dev & Mfg Ops returned 5,597 shares (to the company)
  16. 4 Returned to the company SVP & Chief Medical Officer returned 5,022 shares (to the company)
  17. 4 Returned to the company SVP & Chief Scientific Officer returned 4,782 shares (to the company)
  18. 4 Open-market sale SVP & Chief Operating Officer sold 15,910 shares at $37.78 ($601,080)
  19. 4 Open-market sale SVP Pharma Dev & Mfg Ops sold 5,117 shares at $25.07 ($128,283)
  20. 4 Open-market sale SVP & Chief Scientific Officer sold 396,323 shares at an average $29.00 ($11,493,476)

Page 19 of 49 · 970 filings